We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com.
Community Guidelines: bit.ly/2MgAcio
Alfasigma is a global pharmaceutical company founded almost 80 years ago in Italy, where it is headquartered (in Bologna and Milan).
The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT;), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo).
Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers.
It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.
Read here our social media netiquette: https://it.alfasigma.com/informative-privacy/netiquettesocialnetwork/
We would like to inform you that our current LinkedIn page will be closing soon, and we kindly ask you to follow our second page to stay updated on our latest news:
https://lnkd.in/enTB9gDE
We appreciate your support and loyalty throughout the years and look forward to continuing our relationship with you on our new page.
Best regards,
Nazarbayev University